Over 2 years, tralokinumab was well-tolerated and maintained long-term control of atopic dermatitis in adults. The safety data reported in ECZTEND are consistent with the placebo-controlled parent trials, with adverse events occurring at lower rates. These results support the long-term,…

This article reviews existing and emerging literature on monkeypox. The current outbreak includes infections in new geographic regions, different patterns of transmission, and different prodromal symptoms and cutaneous manifestations. Dermatologists must take careful histories and add monkeypox to their differential…